Efficacy and safety of crizotinib in ALK-positive systemic anaplastic large-cell lymphoma in children, adolescents, and adult patients: results of the French AcSé-crizotinib trial

Laurence Brugières, Nathalie Cozic, Roch Houot, Charlotte Rigaud, David Sibon, Julia Arfi‐Rouche, Pierre Bories, Anne‐Ségolène Cottereau, Alain Delmer, Stéphane Ducassou, Nathalie Garnier, Laurence Lamant, Amaury Leruste, Frédéric Millot, Salma Moalla, Franck Morschhauser, Marie Nolla, Anne Pagnier, Yves Réguerre, Loïc Renaud, Anne Dorothée Schmitt, Mathieu Simonin, Arnaud Verschuur, N. Hoog Labouret, Celine Mahier Ait Oukhatar, Gilles Vassal